Overview
Steven Isakoff is an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Isakoff is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.
He is actively involved in clinical research, co-authoring 129 peer reviewed articles and participating in 9 clinical trials. Dr. Isakoff is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Office
Edwin Choy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choy is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Osteosarcoma, and Synovial Sarcoma. Dr. Choy is currently accepting new patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Frequently Asked Questions about Dr. Steven J. Isakoff
How do I make an appointment with Dr. Steven J. Isakoff?
You can book an appointment with Dr. Steven J. Isakoff by calling their office at 617-726-6500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Steven J. Isakoff a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven J. Isakoff is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Steven J. Isakoff specialize in?
While Dr. Steven J. Isakoff is a Oncology, they have specific expertise in Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Steven J. Isakoff participate in research or clinical trials?
Yes. Dr. Steven J. Isakoff has published 129 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Steven J. Isakoff's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Steven J. Isakoff accept my insurance?
Dr. Steven J. Isakoff accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-726-6500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Isakoff isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Isakoff isDistinguished. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Isakoff isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Isakoff isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Isakoff isDistinguished. Learn about Paget Disease of the Breast.
- PIK3CA-Related Overgrowth SpectrumDr. Isakoff isDistinguished. Learn about PIK3CA-Related Overgrowth Spectrum.
- Triple-Negative Breast CancerDr. Isakoff isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Febrile NeutropeniaDr. Isakoff isAdvanced. Learn about Febrile Neutropenia.
- HER-2 Positive Breast CancerDr. Isakoff isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Experienced
- AgranulocytosisDr. Isakoff isExperienced. Learn about Agranulocytosis.
- Ovarian CancerDr. Isakoff isExperienced. Learn about Ovarian Cancer.